I would disagree on that they’re going to need a lot of cash for expansion.
According to their nov 2024 presentation their current output could be 50 million.
All investments regarding production increase has been made and did cost 2-3 million of which 1.3 million has already been paid year end.
Due to these investments the yearly output is increased to 108 million yearly.
That’s a hell of a return.
A one time investment of 2-3 million increasing the yearly output with 58 million to 108 million.
I don’t mind people having a different opinion, on the contrary as sometimes a different view from others changes mine.
I do not think for one second large investments are needed and a CR is out of the question.
There are a lot of holdings in my portfolio where I’m “worried” about a CR, Bioxyne isn’t one of those.
Add to My Watchlist
What is My Watchlist?
